img

Global Voltaren Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Voltaren Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

The global Voltaren market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Voltaren is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Voltaren is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Voltaren is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Voltaren include Novartis, GSK, Enovachem Pharmaceuticals, Jewim Pharmaceutical, Hainan Quanxing Pharmaceutical, Supor South Ocean, Endo Pharmaceuticals and Iroko Pharmaceuticals, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Voltaren, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Voltaren by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Voltaren market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Voltaren market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Novartis
GSK
Enovachem Pharmaceuticals
Jewim Pharmaceutical
Hainan Quanxing Pharmaceutical
Supor South Ocean
Endo Pharmaceuticals
Iroko Pharmaceuticals
By Type
Tablet
Injection
Gel
Spray
Capsule
By Application
Elderly
Adults
Sales by Region
North America
United States
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Voltaren in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Voltaren manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Voltaren sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Voltaren Definition
1.2 Market by Type
1.2.1 Global Voltaren Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Tablet
1.2.3 Injection
1.2.4 Gel
1.2.5 Spray
1.2.6 Capsule
1.3 Market Segment by Application
1.3.1 Global Voltaren Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Elderly
1.3.3 Adults
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Voltaren Sales
2.1 Global Voltaren Revenue Estimates and Forecasts 2018-2034
2.2 Global Voltaren Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Voltaren Revenue by Region
2.3.1 Global Voltaren Revenue by Region (2018-2024)
2.3.2 Global Voltaren Revenue by Region (2024-2034)
2.4 Global Voltaren Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Voltaren Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Voltaren Sales Quantity by Region
2.6.1 Global Voltaren Sales Quantity by Region (2018-2024)
2.6.2 Global Voltaren Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Voltaren Sales Quantity by Manufacturers
3.1.1 Global Voltaren Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Voltaren Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Voltaren Sales in 2022
3.2 Global Voltaren Revenue by Manufacturers
3.2.1 Global Voltaren Revenue by Manufacturers (2018-2024)
3.2.2 Global Voltaren Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Voltaren Revenue in 2022
3.3 Global Voltaren Sales Price by Manufacturers
3.4 Global Key Players of Voltaren, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Voltaren Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Voltaren, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Voltaren, Product Offered and Application
3.8 Global Key Manufacturers of Voltaren, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Voltaren Sales Quantity by Type
4.1.1 Global Voltaren Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Voltaren Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Voltaren Sales Quantity Market Share by Type (2018-2034)
4.2 Global Voltaren Revenue by Type
4.2.1 Global Voltaren Historical Revenue by Type (2018-2024)
4.2.2 Global Voltaren Forecasted Revenue by Type (2024-2034)
4.2.3 Global Voltaren Revenue Market Share by Type (2018-2034)
4.3 Global Voltaren Price by Type
4.3.1 Global Voltaren Price by Type (2018-2024)
4.3.2 Global Voltaren Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Voltaren Sales Quantity by Application
5.1.1 Global Voltaren Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Voltaren Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Voltaren Sales Quantity Market Share by Application (2018-2034)
5.2 Global Voltaren Revenue by Application
5.2.1 Global Voltaren Historical Revenue by Application (2018-2024)
5.2.2 Global Voltaren Forecasted Revenue by Application (2024-2034)
5.2.3 Global Voltaren Revenue Market Share by Application (2018-2034)
5.3 Global Voltaren Price by Application
5.3.1 Global Voltaren Price by Application (2018-2024)
5.3.2 Global Voltaren Price Forecast by Application (2024-2034)
6 North America
6.1 North America Voltaren Sales by Company
6.1.1 North America Voltaren Revenue by Company (2018-2024)
6.1.2 North America Voltaren Sales Quantity by Company (2018-2024)
6.2 North America Voltaren Market Size by Type
6.2.1 North America Voltaren Sales Quantity by Type (2018-2034)
6.2.2 North America Voltaren Revenue by Type (2018-2034)
6.3 North America Voltaren Market Size by Application
6.3.1 North America Voltaren Sales Quantity by Application (2018-2034)
6.3.2 North America Voltaren Revenue by Application (2018-2034)
6.4 North America Voltaren Market Size by Country
6.4.1 North America Voltaren Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Voltaren Revenue by Country (2018-2034)
6.4.3 North America Voltaren Sales Quantity by Country (2018-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Voltaren Sales by Company
7.1.1 Europe Voltaren Sales Quantity by Company (2018-2024)
7.1.2 Europe Voltaren Revenue by Company (2018-2024)
7.2 Europe Voltaren Market Size by Type
7.2.1 Europe Voltaren Sales Quantity by Type (2018-2034)
7.2.2 Europe Voltaren Revenue by Type (2018-2034)
7.3 Europe Voltaren Market Size by Application
7.3.1 Europe Voltaren Sales Quantity by Application (2018-2034)
7.3.2 Europe Voltaren Revenue by Application (2018-2034)
7.4 Europe Voltaren Market Size by Country
7.4.1 Europe Voltaren Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Voltaren Revenue by Country (2018-2034)
7.4.3 Europe Voltaren Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Voltaren Sales by Company
8.1.1 China Voltaren Sales Quantity by Company (2018-2024)
8.1.2 China Voltaren Revenue by Company (2018-2024)
8.2 China Voltaren Market Size by Type
8.2.1 China Voltaren Sales Quantity by Type (2018-2034)
8.2.2 China Voltaren Revenue by Type (2018-2034)
8.3 China Voltaren Market Size by Application
8.3.1 China Voltaren Sales Quantity by Application (2018-2034)
8.3.2 China Voltaren Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Voltaren Sales by Company
9.1.1 APAC Voltaren Sales Quantity by Company (2018-2024)
9.1.2 APAC Voltaren Revenue by Company (2018-2024)
9.2 APAC Voltaren Market Size by Type
9.2.1 APAC Voltaren Sales Quantity by Type (2018-2034)
9.2.2 APAC Voltaren Revenue by Type (2018-2034)
9.3 APAC Voltaren Market Size by Application
9.3.1 APAC Voltaren Sales Quantity by Application (2018-2034)
9.3.2 APAC Voltaren Revenue by Application (2018-2034)
9.4 APAC Voltaren Market Size by Region
9.4.1 APAC Voltaren Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Voltaren Revenue by Region (2018-2034)
9.4.3 APAC Voltaren Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Voltaren Sales by Company
10.1.1 Middle East, Africa and Latin America Voltaren Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Voltaren Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Voltaren Market Size by Type
10.2.1 Middle East, Africa and Latin America Voltaren Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Voltaren Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Voltaren Market Size by Application
10.3.1 Middle East, Africa and Latin America Voltaren Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Voltaren Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Voltaren Market Size by Country
10.4.1 Middle East, Africa and Latin America Voltaren Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Voltaren Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Voltaren Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Overview
11.1.3 Novartis Voltaren Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Novartis Voltaren Products and Services
11.1.5 Novartis Voltaren SWOT Analysis
11.1.6 Novartis Recent Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK Overview
11.2.3 GSK Voltaren Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 GSK Voltaren Products and Services
11.2.5 GSK Voltaren SWOT Analysis
11.2.6 GSK Recent Developments
11.3 Enovachem Pharmaceuticals
11.3.1 Enovachem Pharmaceuticals Company Information
11.3.2 Enovachem Pharmaceuticals Overview
11.3.3 Enovachem Pharmaceuticals Voltaren Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Enovachem Pharmaceuticals Voltaren Products and Services
11.3.5 Enovachem Pharmaceuticals Voltaren SWOT Analysis
11.3.6 Enovachem Pharmaceuticals Recent Developments
11.4 Jewim Pharmaceutical
11.4.1 Jewim Pharmaceutical Company Information
11.4.2 Jewim Pharmaceutical Overview
11.4.3 Jewim Pharmaceutical Voltaren Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Jewim Pharmaceutical Voltaren Products and Services
11.4.5 Jewim Pharmaceutical Voltaren SWOT Analysis
11.4.6 Jewim Pharmaceutical Recent Developments
11.5 Hainan Quanxing Pharmaceutical
11.5.1 Hainan Quanxing Pharmaceutical Company Information
11.5.2 Hainan Quanxing Pharmaceutical Overview
11.5.3 Hainan Quanxing Pharmaceutical Voltaren Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Hainan Quanxing Pharmaceutical Voltaren Products and Services
11.5.5 Hainan Quanxing Pharmaceutical Voltaren SWOT Analysis
11.5.6 Hainan Quanxing Pharmaceutical Recent Developments
11.6 Supor South Ocean
11.6.1 Supor South Ocean Company Information
11.6.2 Supor South Ocean Overview
11.6.3 Supor South Ocean Voltaren Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Supor South Ocean Voltaren Products and Services
11.6.5 Supor South Ocean Voltaren SWOT Analysis
11.6.6 Supor South Ocean Recent Developments
11.7 Endo Pharmaceuticals
11.7.1 Endo Pharmaceuticals Company Information
11.7.2 Endo Pharmaceuticals Overview
11.7.3 Endo Pharmaceuticals Voltaren Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Endo Pharmaceuticals Voltaren Products and Services
11.7.5 Endo Pharmaceuticals Voltaren SWOT Analysis
11.7.6 Endo Pharmaceuticals Recent Developments
11.8 Iroko Pharmaceuticals
11.8.1 Iroko Pharmaceuticals Company Information
11.8.2 Iroko Pharmaceuticals Overview
11.8.3 Iroko Pharmaceuticals Voltaren Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Iroko Pharmaceuticals Voltaren Products and Services
11.8.5 Iroko Pharmaceuticals Voltaren SWOT Analysis
11.8.6 Iroko Pharmaceuticals Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Voltaren Value Chain Analysis
12.2 Voltaren Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Voltaren Production Mode & Process
12.4 Voltaren Sales and Marketing
12.4.1 Voltaren Sales Channels
12.4.2 Voltaren Distributors
12.5 Voltaren Customers
13 Market Dynamics
13.1 Voltaren Industry Trends
13.2 Voltaren Market Drivers
13.3 Voltaren Market Challenges
13.4 Voltaren Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Voltaren Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Tablet
Table 3. Major Manufacturers of Injection
Table 4. Major Manufacturers of Gel
Table 5. Major Manufacturers of Spray
Table 6. Major Manufacturers of Capsule
Table 7. Global Voltaren Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Voltaren Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 9. Global Voltaren Revenue by Region (2018-2024) & (US$ Million)
Table 10. Global Voltaren Revenue Market Share by Region (2018-2024)
Table 11. Global Voltaren Revenue by Region (2024-2034) & (US$ Million)
Table 12. Global Voltaren Revenue Market Share by Region (2024-2034)
Table 13. Global Voltaren Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 14. Global Voltaren Sales by Region (2018-2024) & (K Units)
Table 15. Global Voltaren Sales Market Share by Region (2018-2024)
Table 16. Global Voltaren Sales by Region (2024-2034) & (K Units)
Table 17. Global Voltaren Sales Market Share by Region (2024-2034)
Table 18. Global Voltaren Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 19. Global Voltaren Sales Quantity Share by Manufacturers (2018-2024)
Table 20. Global Voltaren Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 21. Global Voltaren Revenue Share by Manufacturers (2018-2024)
Table 22. Global Voltaren Price by Manufacturers 2018-2024 (US$/Unit)
Table 23. Global Key Players of Voltaren, Industry Ranking, 2021 VS 2022
Table 24. Global Voltaren Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Voltaren by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Voltaren as of 2022)
Table 26. Global Key Manufacturers of Voltaren, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Voltaren, Product Offered and Application
Table 28. Global Key Manufacturers of Voltaren, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Voltaren Sales Quantity by Type (2018-2024) & (K Units)
Table 31. Global Voltaren Sales Quantity by Type (2024-2034) & (K Units)
Table 32. Global Voltaren Sales Quantity Share by Type (2018-2024)
Table 33. Global Voltaren Sales Quantity Share by Type (2024-2034)
Table 34. Global Voltaren Revenue by Type (2018-2024) & (US$ Million)
Table 35. Global Voltaren Revenue by Type (2024-2034) & (US$ Million)
Table 36. Global Voltaren Revenue Share by Type (2018-2024)
Table 37. Global Voltaren Revenue Share by Type (2024-2034)
Table 38. Voltaren Price by Type (2018-2024) & (US$/Unit)
Table 39. Global Voltaren Price Forecast by Type (2024-2034) & (US$/Unit)
Table 40. Global Voltaren Sales Quantity by Application (2018-2024) & (K Units)
Table 41. Global Voltaren Sales Quantity by Application (2024-2034) & (K Units)
Table 42. Global Voltaren Sales Quantity Share by Application (2018-2024)
Table 43. Global Voltaren Sales Quantity Share by Application (2024-2034)
Table 44. Global Voltaren Revenue by Application (2018-2024) & (US$ Million)
Table 45. Global Voltaren Revenue by Application (2024-2034) & (US$ Million)
Table 46. Global Voltaren Revenue Share by Application (2018-2024)
Table 47. Global Voltaren Revenue Share by Application (2024-2034)
Table 48. Voltaren Price by Application (2018-2024) & (US$/Unit)
Table 49. Global Voltaren Price Forecast by Application (2024-2034) & (US$/Unit)
Table 50. North America Voltaren Revenue by Company (2018-2024) & (US$ Million)
Table 51. North America Voltaren Sales Quantity by Company (2018-2024) & (K Units)
Table 52. North America Voltaren Sales Quantity by Type (2018-2024) & (K Units)
Table 53. North America Voltaren Sales Quantity by Type (2024-2034) & (K Units)
Table 54. North America Voltaren Revenue by Type (2018-2024) & (US$ Million)
Table 55. North America Voltaren Revenue by Type (2024-2034) & (US$ Million)
Table 56. North America Voltaren Sales Quantity by Application (2018-2024) & (K Units)
Table 57. North America Voltaren Sales Quantity by Application (2024-2034) & (K Units)
Table 58. North America Voltaren Revenue by Application (2018-2024) & (US$ Million)
Table 59. North America Voltaren Revenue by Application (2024-2034) & (US$ Million)
Table 60. North America Voltaren Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 61. North America Voltaren Revenue by Country (2018-2024) & (US$ Million)
Table 62. North America Voltaren Revenue by Country (2024-2034) & (US$ Million)
Table 63. North America Voltaren Sales Quantity by Country (2018-2024) & (K Units)
Table 64. North America Voltaren Sales Quantity by Country (2024-2034) & (K Units)
Table 65. Europe Voltaren Sales Quantity by Company (2018-2024) & (K Units)
Table 66. Europe Voltaren Revenue by Company (2018-2024) & (US$ Million)
Table 67. Europe Voltaren Sales Quantity by Type (2018-2024) & (K Units)
Table 68. Europe Voltaren Sales Quantity by Type (2024-2034) & (K Units)
Table 69. Europe Voltaren Revenue by Type (2018-2024) & (US$ Million)
Table 70. Europe Voltaren Revenue by Type (2024-2034) & (US$ Million)
Table 71. Europe Voltaren Sales Quantity by Application (2018-2024) & (K Units)
Table 72. Europe Voltaren Sales Quantity by Application (2024-2034) & (K Units)
Table 73. Europe Voltaren Revenue by Application (2018-2024) & (US$ Million)
Table 74. Europe Voltaren Revenue by Application (2024-2034) & (US$ Million)
Table 75. Europe Voltaren Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 76. Europe Voltaren Revenue by Country (2018-2024) & (US$ Million)
Table 77. Europe Voltaren Revenue by Country (2024-2034) & (US$ Million)
Table 78. Europe Voltaren Sales Quantity by Country (2018-2024) & (K Units)
Table 79. Europe Voltaren Sales Quantity by Country (2024-2034) & (K Units)
Table 80. China Voltaren Sales Quantity by Company (2018-2024) & (K Units)
Table 81. China Voltaren Revenue by Company (2018-2024) & (US$ Million)
Table 82. China Voltaren Sales Quantity by Type (2018-2024) & (K Units)
Table 83. China Voltaren Sales Quantity by Type (2024-2034) & (K Units)
Table 84. China Voltaren Revenue by Type (2018-2024) & (US$ Million)
Table 85. China Voltaren Revenue by Type (2024-2034) & (US$ Million)
Table 86. China Voltaren Sales Quantity by Application (2018-2024) & (K Units)
Table 87. China Voltaren Sales Quantity by Application (2024-2034) & (K Units)
Table 88. China Voltaren Revenue by Application (2018-2024) & (US$ Million)
Table 89. China Voltaren Revenue by Application (2024-2034) & (US$ Million)
Table 90. APAC Voltaren Sales Quantity by Company (2018-2024) & (K Units)
Table 91. APAC Voltaren Revenue by Company (2018-2024) & (US$ Million)
Table 92. APAC Voltaren Sales Quantity by Type (2018-2024) & (K Units)
Table 93. APAC Voltaren Sales Quantity by Type (2024-2034) & (K Units)
Table 94. APAC Voltaren Revenue by Type (2018-2024) & (US$ Million)
Table 95. APAC Voltaren Revenue by Type (2024-2034) & (US$ Million)
Table 96. APAC Voltaren Sales Quantity by Application (2018-2024) & (K Units)
Table 97. APAC Voltaren Sales Quantity by Application (2024-2034) & (K Units)
Table 98. APAC Voltaren Revenue by Application (2018-2024) & (US$ Million)
Table 99. APAC Voltaren Revenue by Application (2024-2034) & (US$ Million)
Table 100. APAC Voltaren Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 101. APAC Voltaren Revenue by Region (2018-2024) & (US$ Million)
Table 102. APAC Voltaren Revenue by Region (2024-2034) & (US$ Million)
Table 103. APAC Voltaren Sales Quantity by Region (2018-2024) & (K Units)
Table 104. APAC Voltaren Sales Quantity by Region (2024-2034) & (K Units)
Table 105. Middle East, Africa and Latin America Voltaren Sales Quantity by Company (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Voltaren Revenue by Company (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Voltaren Sales Quantity by Type (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Voltaren Sales Quantity by Type (2024-2034) & (K Units)
Table 109. Middle East, Africa and Latin America Voltaren Revenue by Type (2018-2024) & (US$ Million)
Table 110. Middle East, Africa and Latin America Voltaren Revenue by Type (2024-2034) & (US$ Million)
Table 111. Middle East, Africa and Latin America Voltaren Sales Quantity by Application (2018-2024) & (K Units)
Table 112. Middle East, Africa and Latin America Voltaren Sales Quantity by Application (2024-2034) & (K Units)
Table 113. Middle East, Africa and Latin America Voltaren Revenue by Application (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Voltaren Revenue by Application (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Voltaren Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 116. Middle East, Africa and Latin America Voltaren Revenue by Country (2018-2024) & (US$ Million)
Table 117. Middle East, Africa and Latin America Voltaren Revenue by Country (2024-2034) & (US$ Million)
Table 118. Middle East, Africa and Latin America Voltaren Sales Quantity by Country (2018-2024) & (K Units)
Table 119. Middle East, Africa and Latin America Voltaren Sales Quantity by Country (2024-2034) & (K Units)
Table 120. Novartis Company Information
Table 121. Novartis Description and Overview
Table 122. Novartis Voltaren Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 123. Novartis Voltaren Product and Services
Table 124. Novartis Voltaren SWOT Analysis
Table 125. Novartis Recent Developments
Table 126. GSK Company Information
Table 127. GSK Description and Overview
Table 128. GSK Voltaren Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 129. GSK Voltaren Product and Services
Table 130. GSK Voltaren SWOT Analysis
Table 131. GSK Recent Developments
Table 132. Enovachem Pharmaceuticals Company Information
Table 133. Enovachem Pharmaceuticals Description and Overview
Table 134. Enovachem Pharmaceuticals Voltaren Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 135. Enovachem Pharmaceuticals Voltaren Product and Services
Table 136. Enovachem Pharmaceuticals Voltaren SWOT Analysis
Table 137. Enovachem Pharmaceuticals Recent Developments
Table 138. Jewim Pharmaceutical Company Information
Table 139. Jewim Pharmaceutical Description and Overview
Table 140. Jewim Pharmaceutical Voltaren Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 141. Jewim Pharmaceutical Voltaren Product and Services
Table 142. Jewim Pharmaceutical Voltaren SWOT Analysis
Table 143. Jewim Pharmaceutical Recent Developments
Table 144. Hainan Quanxing Pharmaceutical Company Information
Table 145. Hainan Quanxing Pharmaceutical Description and Overview
Table 146. Hainan Quanxing Pharmaceutical Voltaren Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 147. Hainan Quanxing Pharmaceutical Voltaren Product and Services
Table 148. Hainan Quanxing Pharmaceutical Voltaren SWOT Analysis
Table 149. Hainan Quanxing Pharmaceutical Recent Developments
Table 150. Supor South Ocean Company Information
Table 151. Supor South Ocean Description and Overview
Table 152. Supor South Ocean Voltaren Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 153. Supor South Ocean Voltaren Product and Services
Table 154. Supor South Ocean Voltaren SWOT Analysis
Table 155. Supor South Ocean Recent Developments
Table 156. Endo Pharmaceuticals Company Information
Table 157. Endo Pharmaceuticals Description and Overview
Table 158. Endo Pharmaceuticals Voltaren Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 159. Endo Pharmaceuticals Voltaren Product and Services
Table 160. Endo Pharmaceuticals Voltaren SWOT Analysis
Table 161. Endo Pharmaceuticals Recent Developments
Table 162. Iroko Pharmaceuticals Company Information
Table 163. Iroko Pharmaceuticals Description and Overview
Table 164. Iroko Pharmaceuticals Voltaren Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 165. Iroko Pharmaceuticals Voltaren Product and Services
Table 166. Iroko Pharmaceuticals Voltaren SWOT Analysis
Table 167. Iroko Pharmaceuticals Recent Developments
Table 168. Key Raw Materials Lists
Table 169. Raw Materials Key Suppliers Lists
Table 170. Voltaren Distributors List
Table 171. Voltaren Customers List
Table 172. Voltaren Market Trends
Table 173. Voltaren Market Drivers
Table 174. Voltaren Market Challenges
Table 175. Voltaren Market Restraints
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Voltaren Product Picture
Figure 2. Global Voltaren Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Voltaren Market Share by Type in 2022 & 2034
Figure 4. Tablet Product Picture
Figure 5. Injection Product Picture
Figure 6. Gel Product Picture
Figure 7. Spray Product Picture
Figure 8. Capsule Product Picture
Figure 9. Global Voltaren Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 10. Global Voltaren Market Share by Application in 2022 & 2034
Figure 11. Elderly
Figure 12. Adults
Figure 13. Voltaren Report Years Considered
Figure 14. Global Voltaren Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 15. Global Voltaren Revenue 2018-2034 (US$ Million)
Figure 16. Global Voltaren Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 17. Global Voltaren Sales Quantity 2018-2034 (K Units)
Figure 18. Global Voltaren Sales Quantity Market Share by Region (2018-2024)
Figure 19. Global Voltaren Sales Quantity Market Share by Region (2024-2034)
Figure 20. North America Voltaren Sales Quantity YoY (2018-2034) & (K Units)
Figure 21. North America Voltaren Revenue YoY (2018-2034) & (US$ Million)
Figure 22. Europe Voltaren Sales Quantity YoY (2018-2034) & (K Units)
Figure 23. Europe Voltaren Revenue YoY (2018-2034) & (US$ Million)
Figure 24. China Voltaren Sales Quantity YoY (2018-2034) & (K Units)
Figure 25. China Voltaren Revenue YoY (2018-2034) & (US$ Million)
Figure 26. APAC Voltaren Sales Quantity YoY (2018-2034) & (K Units)
Figure 27. APAC Voltaren Revenue YoY (2018-2034) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Voltaren Sales Quantity YoY (2018-2034) & (K Units)
Figure 29. Middle East, Africa and Latin America Voltaren Revenue YoY (2018-2034) & (US$ Million)
Figure 30. The Top 10 and Top 5 Players Market Share by Voltaren Sales Quantity in 2022
Figure 31. The Top 10 and Top 5 Players Market Share by Voltaren Revenue in 2022
Figure 32. Voltaren Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Voltaren Sales Quantity Market Share by Type (2018-2034)
Figure 34. Global Voltaren Revenue Market Share by Type (2018-2034)
Figure 35. Global Voltaren Sales Quantity Market Share by Application (2018-2034)
Figure 36. Global Voltaren Revenue Market Share by Application (2018-2034)
Figure 37. North America Voltaren Revenue Market Share by Company in 2022
Figure 38. North America Voltaren Sales Quantity Market Share by Company in 2022
Figure 39. North America Voltaren Sales Quantity Market Share by Type (2018-2034)
Figure 40. North America Voltaren Revenue Market Share by Type (2018-2034)
Figure 41. North America Voltaren Sales Quantity Market Share by Application (2018-2034)
Figure 42. North America Voltaren Revenue Market Share by Application (2018-2034)
Figure 43. North America Voltaren Revenue Share by Country (2018-2034)
Figure 44. North America Voltaren Sales Quantity Share by Country (2018-2034)
Figure 45. United States Voltaren Revenue (2018-2034) & (US$ Million)
Figure 46. Canada Voltaren Revenue (2018-2034) & (US$ Million)
Figure 47. Europe Voltaren Sales Quantity Market Share by Company in 2022
Figure 48. Europe Voltaren Revenue Market Share by Company in 2022
Figure 49. Europe Voltaren Sales Quantity Market Share by Type (2018-2034)
Figure 50. Europe Voltaren Revenue Market Share by Type (2018-2034)
Figure 51. Europe Voltaren Sales Quantity Market Share by Application (2018-2034)
Figure 52. Europe Voltaren Revenue Market Share by Application (2018-2034)
Figure 53. Europe Voltaren Revenue Share by Country (2018-2034)
Figure 54. Europe Voltaren Sales Quantity Share by Country (2018-2034)
Figure 55. Germany Voltaren Revenue (2018-2034) & (US$ Million)
Figure 56. France Voltaren Revenue (2018-2034) & (US$ Million)
Figure 57. U.K. Voltaren Revenue (2018-2034) & (US$ Million)
Figure 58. Italy Voltaren Revenue (2018-2034) & (US$ Million)
Figure 59. Russia Voltaren Revenue (2018-2034) & (US$ Million)
Figure 60. China Voltaren Sales Quantity Market Share by Company in 2022
Figure 61. China Voltaren Revenue Market Share by Company in 2022
Figure 62. China Voltaren Sales Quantity Market Share by Type (2018-2034)
Figure 63. China Voltaren Revenue Market Share by Type (2018-2034)
Figure 64. China Voltaren Sales Quantity Market Share by Application (2018-2034)
Figure 65. China Voltaren Revenue Market Share by Application (2018-2034)
Figure 66. APAC Voltaren Sales Quantity Market Share by Company in 2022
Figure 67. APAC Voltaren Revenue Market Share by Company in 2022
Figure 68. APAC Voltaren Sales Quantity Market Share by Type (2018-2034)
Figure 69. APAC Voltaren Revenue Market Share by Type (2018-2034)
Figure 70. APAC Voltaren Sales Quantity Market Share by Application (2018-2034)
Figure 71. APAC Voltaren Revenue Market Share by Application (2018-2034)
Figure 72. APAC Voltaren Revenue Share by Region (2018-2034)
Figure 73. APAC Voltaren Sales Quantity Share by Region (2018-2034)
Figure 74. Japan Voltaren Revenue (2018-2034) & (US$ Million)
Figure 75. South Korea Voltaren Revenue (2018-2034) & (US$ Million)
Figure 76. China Taiwan Voltaren Revenue (2018-2034) & (US$ Million)
Figure 77. Southeast Asia Voltaren Revenue (2018-2034) & (US$ Million)
Figure 78. India Voltaren Revenue (2018-2034) & (US$ Million)
Figure 79. Middle East, Africa and Latin America Voltaren Sales Quantity Market Share by Company in 2022
Figure 80. Middle East, Africa and Latin America Voltaren Revenue Market Share by Company in 2022
Figure 81. Middle East, Africa and Latin America Voltaren Sales Quantity Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Voltaren Revenue Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Voltaren Sales Quantity Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Voltaren Revenue Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Voltaren Sales Quantity Share by Country (2018-2034)
Figure 86. Middle East, Africa and Latin America Voltaren Revenue Share by Country (2018-2034)
Figure 87. Brazil Voltaren Revenue (2018-2034) & (US$ Million)
Figure 88. Mexico Voltaren Revenue (2018-2034) & (US$ Million)
Figure 89. Turkey Voltaren Revenue (2018-2034) & (US$ Million)
Figure 90. Israel Voltaren Revenue (2018-2034) & (US$ Million)
Figure 91. GCC Countries Voltaren Revenue (2018-2034) & (US$ Million)
Figure 92. Voltaren Value Chain
Figure 93. Voltaren Production Process
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed